N/A N=243 Optical Detection of Intravenous Infiltration:A Pilot Study
Infiltration of Peripheral IV Therapy
Primary: Time Infiltration Detected by Nurse — 29.8; 32.3 hours
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=71 ivWatch Model 400: Device Validation for Infiltrated Tissues
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 96.4 percentage of infiltrations
N/A N=99 ivWatch Sensor: Device Validation for Infiltrated Tissues
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 99.0; 99.0 percentage of infiltrations detected
N/A N=43 ivWatch Model 400: Device Validation for Non-Infiltrated Tissues
Infiltration of Peripheral IV Therapy
Primary: Normal Tissue Red Notification Rate — 0.24 red notifications per day
N/A N=133 Patterns and Prevalence of FDG Extravasation in PET/CT Scans
Intravenous Infiltration
Primary: Number of Participants With Intraveneous Infiltration of FDG During Routine PET/CT Imaging by Visually Assessment of Interpreting Physicians — 17; 32 Participants
Phase 4 N=30 Vapocoolant Spray Used Prior to Intravenous (IV) Insertions
Pain
Primary: Pain Scale Using Visual Analog Scale — 1.13; 1.60 score on a scale
Phase 4 N=67 Infiltration Analgesia After Caesarean Section
Pain, Postoperative · Caesarean Section
Primary: The Demand of Rescue Analgesics (Oxycodone) — 47.5; 57.8 mg — p=0.10
Phase 4 N=150 Local Anesthetics for Pain Reduction Prior to IV Line Placement
Pain · Local Anesthesia for Peripheral Intravenous Catheterization
Primary: Pain Score Following Anesthetic Administration — 2.81; 1.64; 2.05 units on a scale
Phase 4 N=111 Pec Infiltration With Liposomal Bupivacaine for Breast Surgery
Acute Pain
Primary: Total Opioid Use — 0.0; 0.0 mg
N/A N=300 Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients
Pain
Primary: Pain Score on the Numeric Rating Scale (NRS) — 2.3; 4.3 NRS
Phase 4 N=303 Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
Obstruction · Cancer · Ileus
Primary: Prealbumin — 0.15; 0.16 g/l
Phase 4 N=40 VENLID: The Application of a 10%-Lidocaine Spray Prior to the Insertion of a Peripheral Intra-venous Catheter in Female Adults
Pain
Primary: Pain Difference Caused by PIVC (Peripheral Intravenous Catheter) Rated by NRS (Numeric Rating Scale) Between Application of 10% Licocaine Spray and Placebo-for the…
N/A N=350 Peripheral Intravenous Catheter Securement With Tissue Adhesive
Vascular Access Devices
Primary: IV Catheter Survival — 66; 55 Participants
Phase 4 N=50 Continuous Wound Infiltration After Hallux Valgus Surgery
Hallux Valgus
Primary: Average Postoperative Numeric Rating Scale (NRS) for Pain — 2.0; 1.9 units on a scale — p=0.596
N/A N=35 Ultrasound-guided Peripheral IJ Study
IV Access
Primary: Number of Participants With Successful Cannulation of the Internal Jugular Vein — 34 Participants
Phase 4 N=50 Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain
Injections, Intravenous
Primary: Patient Expression of Pain — 0.76; 0.04 units on a scale
N/A N=212 Midlines and Thrombophlebitis
Catheter Infection · Catheter Thrombosis · Catheter Complications
Primary: Upper Extremity CR-UEVT — 7; 11 Participants
N/A N=86 Caudal Block Versus Local Wound Infiltration for Inguinal Procedures
Anesthesia, Caudal
Primary: Comparison of Analgesia Quality Between the Two Groups — 1.86; 3.09; 1.83; 2.95 score on a scale — p=<0.05
Phase 2 N=45 Lidocaine Patches Prior to Intravenous Insertion
Need for Intravenous Catheter
Primary: Pain on Visual Analog Scale (VAS) — 18; 35 mm
Phase 3 N=60 Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride
Coronary Artery Disease · Coronary Artery Stenoses · Valve Regurgitation, Mitral
Primary: Post-operative Pain Intensity — 4.7482; 5.03; 5.75; 6.64 score on a scale
N/A N=974 Isotonic Solution Administration Logistical Testing
Acute Kidney Injury
Primary: Proportion of Isotonic Crystalloid Which is 0.9% Saline — 91.2; 21.0 Percentage of fluid that was saline — p=0.001
Phase 4 N=150 Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Pain · Fever
Primary: To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain in the Hospital Setting. — 0; 0…
N/A N=32 An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement
Dislodged Catheter · Catheter Related Complication
Primary: The Force (Newtons) Required to Dislodge an IV Catheter Secured in the Retrograde Direction. — 28.65; 15.41; 19.29 Newtons
Phase 4 N=100 Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase
Dehydration
Primary: Technical Challenges — 2; 3; 2; 2 participants
N/A N=152 Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
Venous Thrombosis
Primary: Development of DVT (Deep Vein Thrombosis)
Phase 2 N=70 Intravenous(IV) vs. Erector Spinae Plane Blocks in Cardiac Surgery
Erector Spinae Plane Block · Pain Control · Post-Operative Pain, Chronic
Primary: Quantitate the Amount of Opioid Medication Required to Provide Pain Relief-Cumulative First 48 Hours — 80.2; 54.9 Morphine Milligram Equivalents
Phase 4 N=25 Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
Healthy
Primary: The Participant's Assessment of Discomfort at the Infusion Site on a Visual Analog Scale (VAS) — 20.0; 9.4 mm
Phase 4 N=300 Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Pain
Primary: To Determine the Safety of a Single Dose of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain. — 8 Number of Serious Adverse Events
N/A N=71 Effect of IV Lidocaine Infusions on Pain
Pain
Primary: Present Pain Intensity — 6.25; 5.64; 4.92; 4.18 Units on a scale
Phase 4 N=214 Efficacy of IV Acetaminophen Versus Oral Acetaminophen
Nephrectomy
Primary: Total Opioid Dose (MME) Used in 24 Hours — 103.61; 109.17 total morphine milligram equivalents — p=0.3938